Development and Validation of the Kansas City Cardiac Dysautonomia Questionnaire (KCDysQ)
A legfontosabb adatok
- Hol
- Overland Park (Egyesült Államok)Mind a 3 helyszín megnézése
Helyszínek itt: Egyesült Államok
- Kansas City Heart Rhythm InstituteOverland Park, Egyesült ÁllamokContact: Donita AtkinsNo longer taking part
- Midwest Heart and Vascular SpecialistsOverland Park, Egyesült ÁllamokContact: Donita AtkinsNo longer taking part
- Overland Park Regional Medical CenterOverland Park, Egyesült ÁllamokContact: Donita AtkinsNo longer taking part
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakA vizsgálat adatai
- Ki végzi
- Kansas City Heart Rhythm Research Foundation
- Azonosító
- NCT06672861
- A regiszteradat frissítve
- 2025. augusztus 28.
- Eredeti leírás
Main aim will be to compare in patients with cardiac dysautonomia, newly developed disease specific questionnaire to established generalized SF-36 and EQ-5d questionnaires, as there are no disease specific questionnaires for comparison. These novel and established questionnaires will then be compared among groups who have relatively stable disease or stable symptoms with patients who will be expected to have a change in symptoms and QoL.A teljes eredeti leírásKevesebb
Development and Validation of the Kansas City Cardiac Dysautonomia Questionnaire (KCDysQ) in Patients With Postural Orthostatic Tachycardia Syndrome, Inappropriate Sinus Tachycardia, and Other Disorders of Cardiac Dysautonomia
Main aim will be to compare in patients with cardiac dysautonomia, newly developed disease specific questionnaire to established generalized SF-36 and EQ-5d questionnaires, as there are no disease specific questionnaires for comparison. These novel and established questionnaires will then be compared among groups who have relatively stable disease or stable symptoms with patients who will be expected to have a change in symptoms and QoL.
Bevonási feltételek: Patients with a Diagnosis of POTS, IST, or vasovagal syncope.
Kizáró feltételek: Patients with comorbid chronic conditions causing significant impairments in quality of life, defined as:; NYHA Class III or IV Heart Failure; Any patients with current malignancy not in remission; Any patient with history of Autoimmune disease requiring chronic steroid therapy or immunomodulatory agents: Rheumatoid Arthritis, Lupus, Sarcoidosis, Psoriasis All patients with ESRD requiring hemodialysis All patients with cirrhosis of any origin Any patients with solid organ or bone marrow transplant requiring immunosuppressive therapy; COPD GOLD 3 or 4, Group C or D.